• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Specialty Injectables: Ten Key Markets to 2020

  • ID: 2823016
  • May 2014
  • 63 Pages +
  • Greystone Associates

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.


- Analyzes therapeutic demand drivers and evaluates specialty injectables in ten major therapeutic markets

- Analyzes design factors, material selection issues, technologies and market development issues

- Assess significant managed care, technology, and regulatory factors affecting specialty injectable drug markets.

- Provides market data and forecasts to 2020

Note: Product cover images may vary from those shown

1. Executive Summary

2. Anticoagulants

3. Antivirals

4. Autoimmune Diseases

5. Multiple Sclerosis

6. Diabetes

7. Hematopoietics

8. Hormone Replacement

9. Migraine

10. Osteoporosis

11. Reproductive Health

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Bayer AG LEO Laboratories Ltd. Grünenthal GmbH Medtronic, Inc. Teva Pharmaceutical Industries Ltd. Pall Corporation